- Global Pharma News & Resources

Research Partnership publishes new patient syndicated reports - Living with Uterine Fibroids and Endometriosis 2022

Living with Uterine Fibroids (UF) and Endometriosis (Endo) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UF and Endo patient journeys.   

UF and Endo place a similar burden on women, their family and employment opportunities. Women's health is starting to be discussed more widely, so necessary conversations are beginning to open up meaning more women are likely to seek HCP advice and treatment. The Living with UF and Endo reports have been conducted to help pharma identify how patients truly feel, perception of their current treatment options and unmet needs.

Both reports cover the US market, Living with UF (sample of 110 patients) and Living with Endo (sample of 111 patients). The methodologies consisted of 40-minute quantitative online interviews and a small sample of 40-minute qualitative telephone interviews, including patient diary tasks 1 week before the interviews.

Head of Living With, Mariel Metcalfe commented, “Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from Autoimmune, Dermatology and Gastroenterology, and we hope to expand the list of therapy areas year on year.”

About the Research Partnership
Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engage services. As the market insights specialist of this curated group of companies, we collaborate with clients from the global pharmaceutical, medtech and biotech industries, providing research intelligence and strategic recommendations that elevate healthcare brands and power their success.

Editor Details

Last Updated: 06-Sep-2022